News

Published: 07 July 2026

Mini-brains provide insights that animal experiments cannot

Taking the antiepileptic drug Valproate during pregnancy increases the risk of birth defects and autism in children. Animal studies have not yet been able to clarify how the drug impairs the development of the human brain. Using brain organoids grown from human stem cells, researchers have now, for the first time, identified the underlying mechanisms.

Valproate (VPA) is a medication used to treat epilepsy, but it can cause severe harm to an unborn child. Taking the drug during pregnancy significantly increases the risk of congenital malformations and autism spectrum disorders. To investigate the causes of these developmental abnormalities, mice and rats have predominantly been used to date. However, because brain development differs fundamentally between rodents and humans, the findings from such animal experiments lack validity and cannot be reliably translated to humans.

To discover what actually happens in the developing human brain, researchers used modern 3D organoids. These tiny tissue structures (often referred to as “mini-brains”) are grown from human stem cells in the laboratory and closely mimic the early stages of human brain development. The researchers exposed these models to VPA for 30 days to investigate the drug’s effects on developing human nervous tissue.

The results revealed substantial damage: Valproate slowed the growth of the organoids and disrupted the proliferation of key brain cells. Using comprehensive molecular analyses, the researchers identified the underlying mechanism. The drug alters the cells’ immediate environment, leading to a marked overproduction of the so-called extracellular matrix, which includes collagen. This accumulation causes the tissue to become abnormally stiff, preventing cells from communicating properly with one another. As a result, essential structures of the developing brain are severely disrupted.

The study clearly demonstrates that human organoids are highly suitable for understanding how medications interfere with fetal brain development. They provide detailed, human-specific insights into neurobiological processes that animal experiments systematically fail to capture.

References

Yentür et al. Multiomics analysis identifies VPA-induced changes in neural progenitor cells, ventricular-like regions, and cellular microenvironment in dorsal forebrain organoids. Molecular Psychiatry 206; doi: 10.1038/s41380-026-03585-5